Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious OutperformanceFind Stocks Now

AstraZeneca Slips As Judge Sets Timeline, Fine For Delayed Shots

Published 06/18/2021, 11:52 AM
Updated 06/18/2021, 11:53 AM
© Reuters

By Dhirendra Tripathi

Investing.com – AstraZeneca (NASDAQ:AZN) shares fell more than 1% Friday after a Brussels judge’s ordered it to deliver millions of doses of its Covid-19 shots to the European Union, with a penalty if it is unable to do so.

According to an AP report, the European Commission said that the judge had ordered the company to respect a delivery schedule of 15 million doses by July 26, 20 million doses by August 23 and 15 million doses by September 27.

European Commission President Ursula von der Leyen told AP the decision confirms the company had failed to honor its commitments.

The judge also ordered a fine of 10 euros ($12) for every dose not delivered.

The company also claimed victory. “All other measures sought by the European Commission have been dismissed, and in particular the Court found that the European Commission has no exclusivity or right of priority over all other contracting parties,” AstraZeneca said in a note.

The vaccine-maker said the company has supplied more than 70 million doses to the EU and will substantially exceed 80.2 million by the end of this month.

AstraZeneca was seen as the backbone of the EU’s vaccine rollout. Its contract with the European Commission foresaw 300 million doses being distributed initially, with an option for another 100 million, but the speed of deliveries was far slower than the company originally thought.

 

 

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.